Transforming Allergy Treatment

About us

Latest News

girl in a field

March 02.2010
Interim Results and £2.0 million Fundraising
Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines announces interim results for the six months ended 31 December 2009. ...read more

Other news stories
- Preliminary Results for the year ended 30 June 2009 - Confirmation of Management Change - European Patent Granted For MPL-Based Sublingual Vaccines - Proposed Placing and Subscription Offer to Qualifying Participants Approval of waiver of Takeover Code Rule 9 and Notice of General Meeting - Distribution Agreement with Nycomed for Pollinex® R in Canada

View all stories


About Us 

Welcome to the Allergy Therapeutics website. Within this site you will find up-to date information about our Company, who we are and what we do.

We have provided general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy), the only treatment to deal with the underlying cause and not just the symptoms!

Allergy Therapeutics has a long-term commitment to the development of innovative therapies for the treatment and prevention of allergy-related conditions and within this site you will be able to gain an insight into our strategy.

To find out more about us, choose one of the options from the menu on the left.

Company History Overview

Facilities

1934 Foundation of CL Bencard a specialist allergy company in Devon, England.

 

1999 AT sets up new markets in Italy, Spain, Czech & Slovak Republics and Poland.

 

2004 AT floats on Alternative Investment Market London

View company history